181 related articles for article (PubMed ID: 35995278)
1. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation.
Nies AT; Schaeffeler E; Schwab M
Pharmacol Ther; 2022 Oct; 238():108268. PubMed ID: 35995278
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.
Zaïr ZM; Eloranta JJ; Stieger B; Kullak-Ublick GA
Pharmacogenomics; 2008 May; 9(5):597-624. PubMed ID: 18466105
[TBL] [Abstract][Full Text] [Related]
3. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.
Roth M; Obaidat A; Hagenbuch B
Br J Pharmacol; 2012 Mar; 165(5):1260-87. PubMed ID: 22013971
[TBL] [Abstract][Full Text] [Related]
4. Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.
Lee W; Ha JM; Sugiyama Y
J Biol Chem; 2020 Dec; 295(50):17349-17364. PubMed ID: 33051208
[TBL] [Abstract][Full Text] [Related]
5. Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.
Murray M; Zhou F
Br J Pharmacol; 2017 Jul; 174(13):1908-1924. PubMed ID: 28299773
[TBL] [Abstract][Full Text] [Related]
6. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
7. Role of OATP transporters in the disposition of drugs.
Niemi M
Pharmacogenomics; 2007 Jul; 8(7):787-802. PubMed ID: 18240907
[TBL] [Abstract][Full Text] [Related]
8. Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition.
Zhou F; Zhu L; Wang K; Murray M
Adv Drug Deliv Rev; 2017 Jul; 116():21-36. PubMed ID: 27320645
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of human hepatic OATPs: functional consequences and effect on drug pharmacokinetics.
Nie Y; Yang J; Liu S; Sun R; Chen H; Long N; Jiang R; Gui C
Xenobiotica; 2020 Mar; 50(3):297-317. PubMed ID: 31180267
[TBL] [Abstract][Full Text] [Related]
10. SLC Family Transporters.
Liu X
Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models.
Lu X; Chan T; Zhu L; Bao X; Velkov T; Zhou QT; Li J; Chan HK; Zhou F
Eur J Pharm Sci; 2018 Mar; 115():132-143. PubMed ID: 29307856
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.
Shitara Y; Maeda K; Ikejiri K; Yoshida K; Horie T; Sugiyama Y
Biopharm Drug Dispos; 2013 Jan; 34(1):45-78. PubMed ID: 23115084
[TBL] [Abstract][Full Text] [Related]
13. Impact of OATP transporters on pharmacokinetics.
Kalliokoski A; Niemi M
Br J Pharmacol; 2009 Oct; 158(3):693-705. PubMed ID: 19785645
[TBL] [Abstract][Full Text] [Related]
14. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.
Kindla J; Fromm MF; König J
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):489-500. PubMed ID: 19416085
[TBL] [Abstract][Full Text] [Related]
15. The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members.
Seithel A; Glaeser H; Fromm MF; König J
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):51-64. PubMed ID: 18370858
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of the OATP and OAT families.
Marzolini C; Tirona RG; Kim RB
Pharmacogenomics; 2004 Apr; 5(3):273-82. PubMed ID: 15102542
[TBL] [Abstract][Full Text] [Related]
17.
Zhou S; Shu Y
Drug Metab Dispos; 2022 May; 50(9):1238-50. PubMed ID: 35644529
[TBL] [Abstract][Full Text] [Related]
18. Drug uptake systems in liver and kidney.
van Montfoort JE; Hagenbuch B; Groothuis GM; Koepsell H; Meier PJ; Meijer DK
Curr Drug Metab; 2003 Jun; 4(3):185-211. PubMed ID: 12769665
[TBL] [Abstract][Full Text] [Related]
19. SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties.
Pelis RM; Wright SH
Curr Top Membr; 2014; 73():233-61. PubMed ID: 24745985
[TBL] [Abstract][Full Text] [Related]
20. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
